CME Program Detail

Title: Re-Opening Office Practices in the Era of COVID-19
Date: Tue, Jun 9th, 2020
Time: 10:00 am - 11:30 am
Location: Online

Statement of Need:
Planning is vitally important to the success of re-opening your medical practice while participating in reducing virus the spread of the COVID-19. There are a number of considerations to re-opening a medical practice including staffing, supplies, modifications of workflows and finances. It is imperative that physicians create a respective plan that will meet the CDC regulations to reduce the spread of COVID-19 while continuing to provide quality medical care. This program will assist you in creating re-opening strategies and the steps to resume non-essential procedures and managing patient visits.

Target Audience:
Physicians, fellows, residents, students, PAs, NPs, nurse, other healthcare professionals

Speaker:

Joseph Cooke, MD
Title: Associate Professor Clinical Medicine
Associate Professor Health Care Policy and Informatics
Weill Cornell Medical College
Clinical Position(s): Chairman, Department of Medicine
Disclosures: Dr. Segal-Maurer is a Consultant, Investigator and on the Speakers Bureau for Gilead Sciences, HIV Division (No relationship to GS Remdesivir Team)
All of the other presenters do not have any financial relationships to disclose.

Moderators:

Chairpersons
Pamela Williams and Howard Tiszenkel, MD

Committee Members
Joseph Cooke, MD - Gregory Pontone, MD - Jeffrey Rosen, MD - Sorana Segal-Maurer, MD - David Slotwiner, MD

Objectives:

After attending this program attendees will be able to:
1. Prioritize essential in-person visits
2. Plan safety strategies for patients and staff
3. Create a plan for social distancing
4. Comprehend and utilize virtual visit
5. Manage patient flow
6. Utilize lobby screening
7. Identify when COVID-19 pre-testing is essential
8. Manage the use of PPE

Schedule:

10:00am – 10:05am
Introduction
Joseph Cooke M.D.
Medical Group & Hospital Experience To-Date

10:05am – 10:15am
Screening Patients for Office Visits
Jeffrey Rosen, M.D.
3 Tiered Process:
i. Phone
ii. Lobby
iii. Office
c. Educating Staff

10:15am – 10:30am
Office Operations in the COVID-19 Era
Gregory Pontone, M.D.
d. Waiting room
e. Scheduling enough time
f. PPE
g. Social distancing
h. Routine testing:
i. Phlebotomy
ii. ECGs
iii. Other

10:30am – 10:45am
Managing Patients with COVID-19
Sorana Segal-Maurer, M.D.
i. Testing
j. Quarantining
k. Who should be sent to the hospital
l. Treatment

10:45am – 10:50am
Maximizing the Value of Telehealth Visits
David Slotwiner, M.D.
m. Phone vs. video
n. Telehealth platforms
o. Tools for patients
i. BP, HR, ECG, O2 Sat, smartphone apps, etc.
p. Billing
i. CPT codes
ii. Documentation requirements

10:50am – 10:55am
Wrap-up
Jeffrey Rosen, MD

10:55am – 11:30am
Q&A

Accreditation
NewYork Presbyterian/Queens is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.

NewYork Presbyterian/Queens designates this Live Activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Approval for Podiatric Medical Education

NewYork Presbyterian/Queens is approved by the Council on Podiatric Medical Education as a provider of continuing medical education in podiatric medicine. NewYork Presbyterian/Queens has approved this activity for a maximum of 1.50 continuing education contact hours.

Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY, CPME and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.

<< Back to Programs List

<< Back to Program Archive